in contrast to the iddm patients , the insulin-treated niddm subjects exhibited significant reductions in daily insulin requirement ( 72 +/- 6 vs. 58 +/- 9 u/day ) , mean 24-h plasma glucose concentration ( 153 +/- 10 vs. 131 +/- 5 mg/dl ) , glucosuria ( 14 +/- 5 vs. 4 +/- 1 g/day ) , and glycosylated hemoglobin ( 10.3 +/- 0.7 vs. 8.0 +/- 0.4 % ) after glyburide treatment ( all p less than or equal to .05 ) .
C0011854
iddm
C0021641
insulin